SN · Pharma and healthcare · one day
Smith & Nephew (SN): news on Thursday 22 October 2026
News from the 24 hours to Thursday morning, 22 October 2026.
Tone of the day
What the score means. Each score rates how good or bad the news was for the company, from −10 (clearly bad) to +10 (clearly good). 0 is neutral, and anything beyond ±6 is strong and rare. It rates the coverage, not the share price.
Why it scored this way
Coverage centred on the European launch of CARTIHEAL AGILI-C and whether it can help the company regain momentum. A Q4 earnings call transcript was also published, though the headline gives no detail on its content.
What drove it
- CARTIHEAL AGILI-C launch
- Q4 earnings call
Around this day
| Day | Tone | Headlines |
|---|---|---|
| Fri 16 Oct | +4.0 | 5 |
| Sat 17 Oct | +1.3 | 1 |
| Mon 19 Oct | −6.3 | 2 |
| Tue 20 Oct | −0.7 | 3 |
| Wed 21 Oct | +0.3 | 4 |
| Thu 22 Oct | +3.2 | 2 |
| Fri 23 Oct | −3.7 | 7 |
| Sat 24 Oct | −5.7 | 21 |
| Sun 25 Oct | −2.0 | 3 |
| Mon 26 Oct | −1.2 | 4 |
2 stories · 2 headlines · strongest first
Pharma and healthcare on 22 OctoberFTSE 100 that day| Tone | What the article reported, and why it scored that way | |
|---|---|---|
| Cartiheal Agili-C European launch +5.21 headline today · Kalkine asks if Agili-C can help win back momentum. | ||
| +5.2 | European launch of CARTIHEAL AGILI-C seen as potential momentum driver. | |
| Smith & Nephew earnings call transcript +0.71 headline today · 3 in all, since 8 October · A transcript of an earnings call was published. | ||
| +0.5 | Earnings call transcript; factual, no tone or results given in headline. | |
Each article has its own score. The lines are our own summary; follow the source link to read the article itself.
Follow by email
A short, free morning email on how the news treated Smith & Nephew: the tone, the stories behind it, and when coverage starts to turn. Launching soon; one click to unsubscribe.